These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8492420)

  • 21. [Cervical Castleman's disease in a 12 year-old child].
    Chevallier B; Menard P; Franc B; Bertrand JC; Lagardère B; Gallet JP
    Arch Fr Pediatr; 1992 Jan; 49(1):39-41. PubMed ID: 1550449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.
    Kinney MC; Hummell DS; Villiger PM; Hourigan A; Rollins-Smith L; Glick AD; Lawton AR
    J Clin Immunol; 1994 Nov; 14(6):382-90. PubMed ID: 7883866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
    Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
    Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Siltuximab: a new option for the management of Castleman's disease.
    Barquero N
    Drugs Today (Barc); 2015 Jan; 51(1):21-8. PubMed ID: 25685858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.
    Nishimoto N; Sasai M; Shima Y; Nakagawa M; Matsumoto T; Shirai T; Kishimoto T; Yoshizaki K
    Blood; 2000 Jan; 95(1):56-61. PubMed ID: 10607684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of cytokines-interleukin 6 in disease].
    Yoshizaki K
    Rinsho Byori; 1990 Apr; 38(4):375-9. PubMed ID: 2366383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of long term administration of humanized anti-interleukin-6 receptor antibody (tocilizumab) for multicentric Castleman's disease with pulmonary involvement].
    Akahane D; Kimura Y; Sumi M; Sashida G; Gotoh A; Miyazawa K; Ohyashiki K
    Rinsho Ketsueki; 2006 Aug; 47(8):748-52. PubMed ID: 16986713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
    Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
    Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Castleman's disease and sarcoidosis, a rare association resulting in a "mixed" response: a case report.
    Mohammed A; Janku F; Qi M; Kurzrock R
    J Med Case Rep; 2015 Feb; 9():45. PubMed ID: 25884809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical analysis on giant lymph node hyperplasia on neck].
    Ma SH; Liu QJ; Wang J; Yang R
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 44(3):223-6. PubMed ID: 19558862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia with elevated level of serum interleukin-6].
    Mizorogi F; Hattori A; Ogasawara H; Takaki K; Tanaka T
    Rinsho Ketsueki; 1992 Feb; 33(2):221-6. PubMed ID: 1635173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's disease.
    Winter SS; Howard TA; Ritchey AK; Keller FG; Ware RE
    Med Pediatr Oncol; 1996 Jan; 26(1):48-53. PubMed ID: 7494511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Castleman's disease and arterial thrombosis: result of excessively elevated interleukin-6 plasma level?
    Schumacher A; Jacomella V; Stüssi G; Amann-Vesti B; Corti N; Husmann M
    Vasa; 2012 Mar; 41(2):145-8. PubMed ID: 22403134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicentric Castleman's disease complicated by tumor lysis syndrome.
    Lee KD; Lee KW; Choi IS; Yoon SS; Park S; Kim BK; Kim NK
    Ann Hematol; 2004 Nov; 83(11):722-5. PubMed ID: 15316754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Castleman's disease, a fatal cause of lymph node enlargement and fever].
    Verhave G; Lettinga KD; van de Wiel BA; Vasmel WL
    Ned Tijdschr Geneeskd; 2009; 153():A485. PubMed ID: 19857312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Castleman's disease in ear, nose, and throat practice].
    Schrock A; Gutgemann I; Keiner S
    HNO; 2007 May; 55 Suppl 1():E29-32. PubMed ID: 17262216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of multicentric Castleman's disease with multiple pulmonary nodules].
    Doi H; Nakayama T; Satoh K; Sumitomo K; Kawano T; Tatsumi A
    Nihon Kokyuki Gakkai Zasshi; 2002 Sep; 40(9):771-6. PubMed ID: 12607304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multicentric Castleman's disease with lymphoid interstitial pneumonia and polyneuropathy].
    Mizuno I; Murayama T; Obayashi C; Takahashi K; Miyata Y; Ando M; Sato M; Imoto S; Matsui T; Itoh H; Chihara K
    Rinsho Ketsueki; 1998 Aug; 39(8):593-9. PubMed ID: 9785978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute myelogenous leukemia (M2) simultaneously associated with multiple myeloma with special reference to chromosome abnormality of t(6; 14) (p21.1; q32.3)].
    Yashige H; Maekawa T; Fujii H; Nishida K
    Rinsho Ketsueki; 1990 Mar; 31(3):359-64. PubMed ID: 2366341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.